ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Cancer Cell Année : 2023

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

Dates et versions

hal-04253414 , version 1 (22-10-2023)

Identifiants

Citer

Erin Parry, Camilla Lemvigh, Stephanie Deng, Nathan Dangle, Neil Ruthen, et al.. ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome. Cancer Cell, 2023, 41 (10), pp.1803-1816.e8. ⟨10.1016/j.ccell.2023.08.013⟩. ⟨hal-04253414⟩
45 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More